Factors that can affect the external validity of randomised controlled trials - PubMed (original) (raw)

Factors that can affect the external validity of randomised controlled trials

Peter M Rothwell. PLoS Clin Trials. 2006 May.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author declares that he has no competing interests.

Figures

Figure 1

Figure 1. The Absolute Reductions in the Five-Year Risks of Ipsilateral Ischaemic Stroke (Top) and Any Stroke or Death (Bottom) with Surgery in European Carotid Surgery Trial Centres in Which the Median Delay from Last Symptomatic Event to Randomisation Was Less than or Equal to 50 Days (Fast Centres) Compared with Centres with a Longer Delay (Slow Centres)

Data are shown separately for patients with moderate (50%–69%) and severe (70%–99%) carotid stenosis.

Similar articles

Cited by

References

    1. Rothwell PM. External validity of randomised controlled trials: To whom do the results of this trial apply? Lancet. 2005;365:82–93. - PubMed
    1. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–1632. - PubMed
    1. European Carotid Surgery Trialists' Collaborative Group. European Carotid Surgery Trialists' Collaborative Group (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST) Lancet. 1998;351:1379–1387. - PubMed
    1. Fine PEM. Variation in protection by BCG: Implications of and for heterologous immunity. Lancet. 1995;346:1339–1345. - PubMed
    1. Asymptomatic Carotid Atherosclerosis Study Group. Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. JAMA. 1995;273:1421–1428. - PubMed

LinkOut - more resources